HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial
Noor A. M. Bakker(Leiden University), Nienke E. van Trommel(The Netherlands Cancer Institute), Joost H. van den Berg(The Netherlands Cancer Institute), Ekaterina S. Jordanova(Centrum voor Gynaecologische Oncologie Amsterdam), Sanne Samuels(Centrum voor Gynaecologische Oncologie Amsterdam), Jossie Rotman(The Netherlands Cancer Institute), Marc van Beurden(Oncode Institute), Maartje Van Ruiten(The Netherlands Cancer Institute), Tanja D. de Gruijl(Dutch Cancer Society), Karin E. de Visser(Leiden University Medical Center), Jos H. Beijnen(The Netherlands Cancer Institute), Gemma G. Kenter(European Organisation for Research and Treatment of Cancer), Bastiaan Nuijen(The Netherlands Cancer Institute), Ton N. Schumacher(Leiden University Medical Center), Henry Zijlmans(Leiden University Medical Center), John B.A.G. Haanen(Leiden University Medical Center)
Cited by 16
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
|Nature|2015|1.7k
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
|New England Journal of Medicine|2019|1.4k